Suitability depends on the cause and pattern of hair loss, donor supply, scalp health, progression, expectations and medical factors—not simply the number of grafts advertised.
Start by understanding the hair loss
Different causes of hair loss may look similar in photographs. Pattern, speed of change, inflammation, scarring, medicines, illness and family history can affect whether surgery is appropriate. A clinician may recommend investigation or non-surgical management first.
Donor hair is finite
Hair used for transplantation is redistributed, not created. Density, calibre, curl, colour contrast and the size of a stable donor area influence what can reasonably be achieved. Planning must preserve options for future loss rather than using the donor supply for one photograph-ready session.
Age and progression matter
A young person with rapidly changing loss may need a different strategy from someone with a stable pattern. A conservative hairline and staged approach may protect future appearance. A low or dense design that ignores progression can become difficult to maintain.
Technique names do not replace planning
Terms such as FUE or DHI describe parts of extraction or implantation workflows, not a guaranteed result. Ask who performs each stage, how grafts are handled, why a method is proposed and how the plan protects the donor area.
Health, scalp and expectations
Scalp disease, healing history, smoking, medicines and unrealistic density expectations can change risk or suitability. The treating provider should discuss scarring, temporary shedding, uneven growth, infection, over-harvesting and possible need for additional treatment.
Questions for an international consultation
Ask for the provider identity, assessment basis, estimated rather than guaranteed graft range, hairline rationale, team roles, aftercare, warning signs, record transfer and what happens if the in-person findings differ from the remote discussion.
How Estelion supports communication
Estelion coordinates enquiries, record transfer, travel communication and contact with an authorised treatment provider. The responsible provider performs the clinical assessment, explains alternatives and risks, obtains consent and delivers any treatment. An initial remote exchange is informational and may change after direct examination.

